On January 3, 2023, Shanghai Biotree BIOTECH Co., Ltd., a leading Chinese metabolomics research company, announced the completion of a strategic financing round of CNY 10 Million A+.
Burning Rock Biotech said Thursday that it has entered a strategic partnership with Merck to develop a companion diagnostic for the MET inhibitor tepotinib (Tepmetko) in the mainland China market, using Burning Rock's OncoCompass Target panel.
✔ All (2)
✔ Press release (0)
✔ Industry news (2)
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.